Cargando…
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
Hsulf-1 is a newly identified enzyme, which has the ability to decrease the growth of hepatocellular, ovarian, and head and neck squamous cell carcinoma cells by interfering with heparin-binding growth factor signaling. Since pancreatic cancers over-express a number of heparin-binding growth factors...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087876/ https://www.ncbi.nlm.nih.gov/pubmed/15817123 http://dx.doi.org/10.1186/1476-4598-4-14 |